IntelGenx Technologies Corp. (IGXT) Stock Quote

Detailed Quote for IntelGenx Technologies Corp. (IGXT)

close 52 Week Information

52 Week High

July 14, 2011

Close: 1.06

52 Week Low

December 9, 2011

Close: 0.40

Today

Last Price
0.734

Change $
0.024

Change %
3.38%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
0.71

High
0.739

Low
0.681

Prev Close
0.71

Last Trade
2/10/12

Volume
244.96 k

52 Wk Hi
1.06

52 Wk Low
0.40

Market Cap
33.92 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
46,215,511

EPS (TTM)
N/A

PE Ratio
N/A

close Exchange Information Listed On OTC Bulletin Board Consolidated (OTCBB) Exchange
OTCBB

News and Media for IntelGenx Technologies Corp. (IGXT)

Sector News | Topic News

News for IGXT

Thu, Jan 05, 2012

4:42 PM

IntelGenx to Present at Biotech Showcase 2012 - Globe Newswire

Thu, Dec 22, 2011

4:29 PM

IntelGenx Announces Health Canada Approval for Anti-Migraine VersaFilm Pivotal Clinical Trial - Globe Newswire

4:12 PM

IntelGenx Announces Health Canada Approval for Anti-Migraine VersaFilm Pivotal Clinical Trial - Newsfile

Wed, Dec 21, 2011

6:07 AM

IntelGenx Announces Development and Commercialization Agreement With Par Pharmaceutical, Inc. - Globe Newswire

6:00 AM

IntelGenx Announces Development and Commercialization Agreement with Par Pharmaceutical, Inc. - Newsfile

Wed, Nov 30, 2011

4:28 PM

IntelGenx Grants Stock Options - Globe Newswire

4:03 PM

IntelGenx Grants Stock Options - Newsfile

Tue, Nov 15, 2011

8:16 AM

Speculative Healthcare Companies IntelGenx and Adventrx Begin to Gain Ground - Marketwire

Fri, Nov 11, 2011

6:10 AM

IntelGenx Announces FDA Approval of Its High Dose Anti-Depressant CPI-300 - Globe Newswire

6:00 AM

IntelGenx Announces FDA Approval of its High Dose Anti-Depressant CPI-300 - Newsfile

Wed, Nov 09, 2011

12:08 PM

IntelGenx Reports Q3, 2011 Results - Globe Newswire

12:00 PM

IntelGenx Reports Q3, 2011 Results - Newsfile

Mon, Nov 07, 2011

8:53 AM

Exclusive: President and CEO of IntelGenX Discusses the Firm's Pending FDA Decision - Marketwire

5:10 AM

FDA Revises IntelGenx' CPI-300 PDUFA Date to November 10th - Globe Newswire

5:00 AM

FDA Revises IntelGenx' CPI-300 PDUFA Date to November 10th - Newsfile

Tue, Sep 06, 2011

6:00 AM

IntelGenx to Present at the Rodman & Renshaw 13th Annual Healthcare Conference in New York - Globe Newswire

Tue, Aug 09, 2011

6:00 AM

IntelGenx Reports Q2, 2011 Results and Highlights Recent Developments - Marketwire

Tue, Aug 02, 2011

6:00 AM

IntelGenx Announces Successful Pre-Approval Inspection of its Lead Product CPI-300 - Marketwire

6:00 AM

IntelGenx Announces Successful Pre-Approval Inspection of its Lead Product CPI-300 - Marketwire Canada

Wed, Jun 22, 2011

10:37 AM

IntelGenx Announces Closing of Private Placements - Marketwire Canada

More News for IGXT >>

Tags for IntelGenx Technologies Corp.

Research stocks or mutual funds related to IntelGenx Technologies Corp. by keywords or tags. Find companies that have a similar focus to IGXT. The keywords below have been associated to IGXT by either user submission or electronic means.

Diversified Services Research and Development in the Physical, Engineering, and Life Sciences (541710) pharmaceutical industry strategy sec regulation pharmaceutical market Services Commercial Physical And Biological Research (8731) generic pharmaceutical niche pharmaceutical pharmaceutical training pharmaceutical process development private placement investing biotechnology market pharmaceutical research and development accredited investors pharmaceutical manufacturing company biotech and pharmaceutical pharmaceutical position investment shares pharma manufacturing pharmaceutical class generic products pharmaceutical sales pharma securities regulation pharmaceutical solution pharmaceutical development securities broker pharmaceutical isolators pharmaceutical sales rep pharmaceutical production pharmaceutical consultant restricted securities pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharma stocks pfizer pharmaceuticals generic pharmaceuticals pharmaceutical consulting pharmaceutical industry pharmaceutical studies pharmaceutical strategy pharmaceutical advances sec securities pharmaceutical jobs pharmaceutical standards pharmaceutical business development